Skip to main content
SpringerLink
Log in

Impact of AEs on resource-related costs in HCV patients

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2013 British pounds

Reference

  • Akpo EI, et al. Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilization-Related Costs in Hepatitis C Genotype 1 Treatment-Naive Patients Receiving Antiviral Therapy. PharmacoEconomics : 11 Jan 2015. Available from: URL: http://doi.org/10.1007/s40273-014-0249-4

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Impact of AEs on resource-related costs in HCV patients. PharmacoEcon Outcomes News 720, 19 (2015). https://doi.org/10.1007/s40274-015-1858-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-1858-7

Search

Navigation